SCHEMBL4244247

SCHEMBL4244247

O=C(O)c1c(O)cc(-c2ccccc2)oc1=O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.77
L3MBTL1 Q9Y468 2/20 0.77
POLB P06746 1/20 0.77
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
PTGES O14684 1/20 0.49
HSP90AA1 P07900 1/20 0.49
MAPT P10636 6/20 0.47
ALDH1A1 P00352 5/20 0.47
KDM4E B2RXH2 5/20 0.47
FTO Q9C0B1 5/20 0.47
ALOX15 P16050 4/20 0.47
CYP3A4 P08684 4/20 0.47
TP53 P04637 4/20 0.47
HPGD P15428 4/20 0.47
HSD17B10 Q99714 4/20 0.47
CYP1A2 P05177 4/20 0.47
CYP1B1 Q16678 4/20 0.47
CYP19A1 P11511 4/20 0.47
CYP1A1 P04798 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7370116 0.87 SMN1; SMN2 (1.00) SMN1; SMN2L3MBTL1POLBMEN1KMT2A
SCHEMBL4369997 0.87 SMN1; SMN2 (0.72) SMN1; SMN2L3MBTL1POLBMEN1KMT2A
SCHEMBL5632532 0.87 SMN1; SMN2 (0.72) SMN1; SMN2L3MBTL1POLBMEN1KMT2A
SCHEMBL4237733 0.83 POLB (0.67) SMN1; SMN2L3MBTL1POLBMEN1KMT2A
SCHEMBL6962833 0.77 SMN1; SMN2 (0.59) SMN1; SMN2L3MBTL1POLBMEN1KMT2A
Hydrochloric Acid SCHEMBL7373131 0.76 SMN1; SMN2 (0.58) SMN1; SMN2L3MBTL1POLBMEN1KMT2A
SCHEMBL6952636 0.76 SMN1; SMN2 (0.58) SMN1; SMN2L3MBTL1POLBMEN1KMT2A
SCHEMBL6958076 0.76 SMN1; SMN2 (0.58) SMN1; SMN2L3MBTL1POLBMEN1KMT2A
SCHEMBL3513442 0.75 SMN1; SMN2 (0.56) SMN1; SMN2L3MBTL1POLBMEN1KMT2A
SCHEMBL3510451 0.74 L3MBTL1 (0.54) SMN1; SMN2L3MBTL1POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203694-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE HURLEY TIMOTHY BRIAN 2009-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203694-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE FDPS, UMPS, GGPS1 SMN1; SMN2 4143/4885L3MBTL1 2061/4885POLB 470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.